Wolfgang Luepcke, Dimitar Yakimov, Julia Ferencz, Iliyana Nacheva, Axel Wehrend, Plamen Georgiev, Teodora Sarakostova, Eva Krieps


Enterohemorrhagic Еscherichia соli bacteria (EHEC) as well as Rota and Coronaviruses are very dangerous pathogens of severe intestinal infections in humans and animals, which require a very special approach. EHEC contraindicates the use of antibiotics, as they destroy the bacteria and release their endotoxins as a result which can lead to permanent kidney damage and even death in patients. Antibiotics are ineffective with viral pathogens, possibly only preventing secondary bacterial infections.

Based on Luepcke's many years of laboratory and practical tests, we therefore recommend the targeted use of specific colostral antibodies for the above-mentioned intestinal infections. These are obtained by means of combined intramammary and intracisternal application of attenuated pathogen isolates or vaccine strains in dry cows and goats. In this way, the first colostrum with high antibody titres is obtained, which also contains large amounts of trypsin inhibitor and thus protects the antibodies against proteolytic splitting. The first colostrum is therefore particularly valuable, because it ensures the integrity and functionality of the antibodies. This is both a basic prerequisite for their passage from the intestinal lumen into the blood (passive humoral immunity) and also ensures the effectiveness of the non-absorbed antibodies in the intestinal lumen and on the intestinal mucosa (passive local immunity). In order to accelerate the elimination of the antigen-antibody complexes that arise in the intestine in this approach, Yakimov recommends the use of a sorbent that cannot be absorbed via the intestine. Cryopreservation enables simple storage and, if necessary, easy shipping of the first colostrum produced targeted against the respective infectious agents which is to be regarded as a food supplement with simultaneous effect as an immunopreparation.


colostrum, trypsininhibitor, maternal antibodies, immunity, Escheriсhia coli, Rotavirus, Coronavirus

Full Text:



Georgiev, G. i H. Haralambiev, 1988. Vet. sbirka, br. 7, str. 11.

Lyupke, V. i V. Yonkova, 1991. Sbornik - Harkov „5 godini sled Chernobil“ str. 32.

Lyupke, V., Sb. „Dni na naukata - 1999“, Veliko Tarnovo, str. 194.

Filipov, Ch., V. Lyupke, V. Yonkova i H. Haralambiev, 2013. Sbornik - St. Zagora.

Anonym, 1966. Taschenbuch fuer Tieraerzte “DESSAU” – VEB GUSTAV - FISCHER-VERLAG Jena, pp. 68.

Baljer, G. und L. H. Wieler, 1998. Lohmann Information 4, pp. 19.

Baljer, G. and R. Bauerfeind, 1977. Material Kongress der beamteten Tieraerzte Dresden.

Bockemuehl, J. und H. Karch, 1999. Bundesgesundheitsblatt, 39 (8), pp. 290-296.

Iburg, M, 1997. Lohmann Information, 20, pp. 37-43.

Karch, H. und J. Bockemuehl, 1989. Infekt.Immun.17, pp. 206-211.

Korsun, N., 2017. Caliciviruses. In: Korsun N. (Edts.). Viral intestinal infections, pp. 99–115.

Lüpcke und Mitarb, 2017. Materialien 15.Büffelkongress Penig/Deutschland – 20.

Olano-Martin Estibaliz, Marte R.Williams, Glenn R.Gibson and Robert R.Rasfall, 2003. FEMS, Microbiology Letters 218, pp. 101-105.

Pirro, F., L.H. Wieler, K. Failing, R. Bauerfeind and G. Baljer, 1995. Vet. Mikrobiol., 43, pp. 131-14.

Yulian, T., Z. Denkova, V. Yanakieva, Il. Dobrev, R. Denkova, 2013. Role of the noroviruses as substantial foodborne pathogens: A review, Sb. „Nauchni trudove na Rusenski universitet, tom 52, seriya 10.2, str. 70-74.

Wieler, L.H., R. Bauerfeind und G. Baljer, 1992. Tieraerztl. Umschau 47, pp. 524 533.


  • There are currently no refbacks.

New knowledge Journal of science is financed by the National Science Fund of the Republic of Bulgaria - contract № КП-06-НП1/5 of 17.12.2019 in the competition of Bulgarian scientific periodicals – 2019

New knowledge Journal of science is financed by the National Science Fund of the Republic of Bulgaria – contract № ДНП 05/52 от 22.12.2016 in the competition of Bulgarian scientific periodicals – 2016

The contents of this publication do not necessarily reflect the position or opinion of the National Science Fund of the Republic of Bulgaria. The opinions expressed are those of the author(s) only and should not be considered as representative of the National Science Fund’s official position.


National Science Fund of Bulgaria